AKT1 and Alzheimer disease: In 3 × Tg‐AD mice [64] and APP/PS1 mice [277], decreased level of cerebral insulin receptor‐β is also observed, accompanied with suppression of insulin signaling pathway (PI3K/Akt/GSK‐3β) [277], indicating the hypofunction of insulin pathway in AD cases.